Evidence map›Paper›PMID 30787142›Full record

ArticleJournal of clinical microbiology2019

Development of a Multiplexed Assay for Detection of

Claudia Abeijon, Fabiana Alves, Severine Monnerat, Monique Wasunna, Jane Mbui, Agostinho G Viana, Lilian L Bueno, Williane F Siqueira, Silvio G Carvalho, Neha Agrawal and 3 more

Open access · bronzeAbstract readValidation Study
In one paragraph

Article in Journal of clinical microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Proteomic Analysis of Urine from Patients withTropical medicine and infectious disease · 2022
    Article
  6. Article
  7. Article
  8. Review
  9. Molecular Tracking of theFrontiers in cellular and infection microbiology · 2021
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 5 countries.

Claudia AbeijonDetectoGen Inc., Grafton, Massachusetts, USA.
Fabiana AlvesDrugs for Neglected Diseases Initiative, Geneva, Switzerland.
Severine MonneratDrugs for Neglected Diseases Initiative, Geneva, Switzerland.
Monique WasunnaKEMRI Centre for Clinical Research, Nairobi, Kenya.
Jane MbuiKEMRI Centre for Clinical Research, Nairobi, Kenya.
Agostinho G VianaFederal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Lilian L BuenoFederal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Williane F SiqueiraFederal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Silvio G CarvalhoState University of Montes Claros, Montes Claros, MG, Brazil.
Neha AgrawalTemple University, Philadelphia, Pennsylvania, USA.
Ricardo FujiwaraFederal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Shyam SundarInstitute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Antonio Campos-NetoDetectoGen Inc., Grafton, Massachusetts, USA acampos@detectogen.com.ORCID 0000-0003-1355-2798
Universidade Federal de Minas Gerais · BRDrugs for Neglected Diseases Initiative · CHKenya Medical Research Institute · KEInstitute of Medical Sciences · INTemple University · USTufts University · USUniversidade Estadual de Montes Claros · BR

Funding

Novel non-invasive antigen detection assay for the diagnosis of active visceral leishmaniasis and to monitor the therapy efficacy of this diseaseR44AI113992 · NIAID · DETECTOGEN, INC. · PI ABEIJON, CLAUDIA · 2017 to 2019
$1.9M
NIAID NIH HHS R44 AI113992
6 · The paper itself

Abstract

Visceral leishmaniasis (VL) is a serious and fatal disease caused by the parasites

Indexed as

AdolescentAdultAgedAntibodies, ProtozoanBiomarkersBrazilChildChild, PreschoolEnzyme-Linked Immunosorbent AssayFemaleHigh-Throughput Screening AssaysHumansIndiaKenyaLeishmania donovaniLeishmania infantumAntibodies, ProtozoanBiomarkersProtozoan Proteinsantigen detection testantigenuriaLeishmania donovaniLeishmania infantumvisceral leishmaniasis

Identifiers

PMID30787142
PMCPMC6497999
OpenAlexW2917115993

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.